Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Mehr anzeigen
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.08 | -4.27807486631 | 1.87 | 1.94 | 1.71 | 1161239 | 1.8499884 | CS |
| 4 | -0.78 | -30.3501945525 | 2.57 | 2.63 | 1.71 | 1765607 | 2.07373815 | CS |
| 12 | -2.92 | -61.9957537155 | 4.71 | 6.14 | 1.71 | 1229239 | 3.08424878 | CS |
| 26 | -2.74 | -60.4856512141 | 4.53 | 6.78 | 1.71 | 856103 | 3.86663834 | CS |
| 52 | -6.1 | -77.3130544994 | 7.89 | 8.9 | 1.71 | 764092 | 4.71452948 | CS |
| 156 | -19.51 | -91.5962441315 | 21.3 | 22.05 | 1.71 | 662870 | 7.52518767 | CS |
| 260 | -15.87 | -89.8640996602 | 17.66 | 45 | 1.71 | 708849 | 14.25493983 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
